The binding of aurovertin to mitochondria, and its effect on mitochondrial respiration.
D000251:Adenosine Triphosphatases; D000494:Allosteric Regulation; D000693:Anaerobiosis; D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism*; D000963:Antimetabolites / Q000378:metabolism*; D000968:Antimycin A / Q000494:pharmacology; D001665:Binding Sites; D006027:Glycosides / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006898:Hydroxylamines / Q000494:pharmacology; D008928:Mitochondria / Q000201:enzymology / Q000378:metabolism*; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism; D008931:Mitochondria, Muscle / Q000187:drug effects / Q000378:metabolism; D009206:Myocardium / Q000166:cytology / Q000378:metabolism; D009840:Oligomycins / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D011485:Protein Binding; D051381:Rats
D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D006027:Glycosides; D006898:Hydroxylamines; D009840:Oligomycins; D000968:Antimycin A; D000251:Adenosine Triphosphatases